FREE RADICALS AND CHOLINE DEFICIENT LIVER CARCINOGENESIS
自由基和胆碱缺乏性肝癌的发生
基本信息
- 批准号:6701800
- 负责人:
- 金额:$ 38.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-03 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:AP1 proteinapoptosisathymic mousecarcinogenesis inhibitorchemical carcinogenesischoline deficiencyepidermal growth factorfibroblast growth factorfree radical scavengershepatocellular carcinomahydrogen peroxidelaboratory ratmitochondrial membraneneoplasm /cancer nutrition therapynonhuman therapy evaluationnuclear factor kappa betanutrition aspect of cancernutrition related neoplasm /cancernutrition related tagpreneoplastic stateprostaglandin Eprostaglandin endoperoxide synthasetransforming growth factorstumor suppressor proteins
项目摘要
Reactive oxygen species (ROS) have been implicated in cancer development for many years. A prime example where ROS are strongly implicated is the model system where feeding a choline deficiency (CD) diet to rats leads to hepatocellular carcinoma (HCC) development, i.e., in the complete absence of exposure to any exogenous known carcinogen. Utilizing this model, we have made novel observations that make it possible to link ROS with key signal transduction pathways that have been shown to be fundamental in cancer initiation and development. For the first time we have shown that mitochondria from CD-livers are changed such that they mediate a significantly higher yield of H202 production. Additionally, for the first time we have shown that PBN (a- phenyl-tent-butyl nitrone), a nitrone-based free radical trap, significantly reduces preneoplastic nodule development as well as inhibits hepatocellular carcinoma (HCC) formation at very low levels of the compound. PBN is the most potent anti-carcinogen ever studied in this model. To explain these observations we postulate that the CD-regimen mediates changes in mitochondrial membranes such that they produce enhanced levels of H2O2 and that PBN significantly inhibits the excess H202 production by acting at Complex 1. We further postulate that excess H202 causes an enhanced inactivation of the PTEN tumor suppressor protein, which causes a loss of its phosphatase activity and thereby mediates a shift toward the activation of the AKT-kinase pathway resulting in a decrease in apoptosis medicated processes but an increase in oncogenic events. We further propose that the cells in preneoplastic nodules that develop in CD-livers are predisposed toward oncogenesis (as opposed to apoptosis) because of the action of excess H202 and certain growth factors (most likely TGFbeta1) and that PBN alters these processes through both its inhibition of excess H202 production and also by suppression of enhanced signal transduction processes. We propose that PBN acts to cause the prenoplastic nodule cells to become predisposed toward apoptic processes thus leading to inhibition of tumor development. To test this hypothesis we have proposed 3 specific aims. Briefly they are: A) We will determine the nature of the alterations in mitochondrial membranes that cause them to produce excess H202. B) We will focus on the mechanisms of how H2O2 acts as a signaling molecule and the action of PBN in altering signal transduction processes in cell models. C) We will determine if PBN (or its metabolite 4-OH-PBN) inhibits CD-mediated HCC development and ascertain if these compounds increase apoptosis in preneoplastic cells in this model.
活性氧(ROS)与癌症的发展有关已有多年。其中ROS被强烈牵连的主要实例是模型系统,其中向大鼠喂食胆碱缺乏(CD)饮食导致肝细胞癌(HCC)发展,即,在完全没有暴露于任何外源性已知致癌物质的情况下。利用这个模型,我们进行了新的观察,使其有可能连接ROS与关键的信号转导途径,已被证明是癌症的发生和发展的基础。我们第一次表明来自CD-肝脏的线粒体被改变,使得它们介导显著更高的H2 O2产生产率。此外,我们第一次表明PBN(a-苯基-叔丁基硝酮),一种硝酮基自由基捕获剂,在非常低的化合物水平下显著减少癌前结节的发展并抑制肝细胞癌(HCC)的形成。PBN是该模型中有史以来研究过的最有效的抗癌物质。为了解释这些观察结果,我们假设CD方案介导线粒体膜的变化,使得它们产生增强水平的H2 O2,并且PBN通过作用于复合物1而显著抑制过量的H2 O2产生。我们进一步假设过量的H2 O2导致PTEN肿瘤抑制蛋白的增强的失活,这导致其磷酸酶活性的丧失,从而介导朝向AKT-激酶途径的活化的转变,导致细胞凋亡介导的过程减少,但致癌事件增加。我们进一步提出,由于过量的H2 O2和某些生长因子(最可能是TGF β 1)的作用,在CD-肝脏中发展的癌前结节中的细胞倾向于肿瘤发生(与凋亡相反),PBN通过抑制过量的H2 O2产生和抑制增强的信号转导过程来改变这些过程。我们认为PBN的作用是使癌前结节细胞倾向于增生过程,从而抑制肿瘤的发展。为了验证这一假设,我们提出了三个具体目标。简言之,它们是:A)我们将确定线粒体膜中导致它们产生过量H2 O2的改变的性质。B)我们将重点关注H2 O2如何作为信号分子的机制以及PBN在改变细胞模型中信号转导过程中的作用。C)我们将确定PBN(或其代谢物4-OH-PBN)是否抑制CD介导的HCC发展,并确定这些化合物是否在该模型中增加癌前细胞的凋亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A FLOYD其他文献
ROBERT A FLOYD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A FLOYD', 18)}}的其他基金
OMRF MRI SYSTEM: BEHAVIORAL PHARMACOLOGY OF ABUSED DRUG LIKE ALCOHOL, LIVER INJU
OMRF MRI 系统:酒精、肝脏损伤等滥用药物的行为药理学
- 批准号:
6973144 - 财政年份:2004
- 资助金额:
$ 38.59万 - 项目类别:
OMRF MRI SYSTEM: AGING, ALZHEIMER'S DIS, ALS
OMRF MRI 系统:衰老、阿尔茨海默病、ALS
- 批准号:
6973142 - 财政年份:2004
- 资助金额:
$ 38.59万 - 项目类别:
OMRF MRI SYSTEM: CANCER: LIVER, COLON, E FAECALIS
OMRF MRI 系统:癌症:肝癌、结肠癌、粪肠球菌
- 批准号:
6973141 - 财政年份:2004
- 资助金额:
$ 38.59万 - 项目类别:
OMRF MRI SYSTEM: WEGENER'S GRANULOMATOSIS, CVD
OMRF MRI 系统:韦格纳肉芽肿病、CVD
- 批准号:
6973145 - 财政年份:2004
- 资助金额:
$ 38.59万 - 项目类别:
OMRF MRI SYSTEM: PROTEOMICS, RETINA & LIPID METABOLISM, LUNG DISEASES
OMRF MRI 系统:蛋白质组学、视网膜
- 批准号:
6973143 - 财政年份:2004
- 资助金额:
$ 38.59万 - 项目类别:
FREE RADICALS AND CHOLINE DEFICIENT LIVER CARCINOGENESIS
自由基和胆碱缺乏性肝癌的发生
- 批准号:
6286902 - 财政年份:2001
- 资助金额:
$ 38.59万 - 项目类别:
FREE RADICALS AND CHOLINE DEFICIENT LIVER CARCINOGENESIS
自由基和胆碱缺乏性肝癌的发生
- 批准号:
6628206 - 财政年份:2001
- 资助金额:
$ 38.59万 - 项目类别:
FREE RADICALS AND CHOLINE DEFICIENT LIVER CARCINOGENESIS
自由基和胆碱缺乏性肝癌的发生
- 批准号:
6497568 - 财政年份:2001
- 资助金额:
$ 38.59万 - 项目类别:
FREE RADICALS AND CHOLINE DEFICIENT LIVER CARCINOGENESIS
自由基和胆碱缺乏性肝癌的发生
- 批准号:
6849725 - 财政年份:2001
- 资助金额:
$ 38.59万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
- 批准号:31970691
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
- 批准号:31900527
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
姜黄素与TRAIL的协同抗肿瘤机制研究
- 批准号:31101223
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
- 批准号:81100502
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
- 批准号:
10538142 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
The Gut as a Target to Improve Outcomes in Sepsis
肠道作为改善脓毒症预后的目标
- 批准号:
10552403 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
Mechanisms of Parp inhibitor-induced bone marrow toxicities
Parp 抑制剂诱导骨髓毒性的机制
- 批准号:
10637962 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别: